Optometry Times

2024 was an action-packed year for advancements in age-related macular degeneration (AMD) treatments, trials, and research. With the prevalence of AMD projected to continue rising in the coming decades, staying informed on the latest ways to diagnose the disease and slow its progression will remain essential to quality patient care in the field of optometry. Get caught up on what you may have missed with this year’s top content in AMD from Optometry Times. Read more: https://lnkd.in/efrmhSrq

Experienced optometrists are providing advice for residents on making the most of the residency experience. A common theme of said advice is the importance of actively engaging in research and publishing during residency. Pam Theroit, OD, FAAO, emphasizes that learning how to thoroughly research and write peer-reviewed papers is a critical skill that will serve you well beyond residency. Residency provides the mentorship and resources to develop these research skills, which can then be applied to expand the medical knowledge base. Watch the video: https://lnkd.in/ggVzKtvG

As the optometry track of the EnVision Summit expands in 2025, so does attendee excitement for the conference, to be held from February 14-17 in Puerto Rico. Conference Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; share what they find makes EnVision special and what they plan to take part in during the conference. Watch the video: https://lnkd.in/eG2nzagc

Iranian researchers led by first author Arash Mirmohammadsadeghi, MD, reported that treating adults with amblyopia with fluoxetine resulted in increased visual acuity (VA) in the amblyopic eyes that was significant compared with control eyes. He and his colleagues are from the Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. They reached this conclusion based on the results of a double-blinded, randomized, clinical trial (IRCT20180316039110N1) performed between November 2017 and December 2022 in the strabismus clinic of Farabi Eye Hospital. Read more: https://lnkd.in/eZM7Rkbf

As 2024 comes to a close, it is a perfect time to reflect on the significant developments and insights that have emerged in the field of optometry this year. From advancements in myopia control to sustainability in contact lens prescriptions, the landscape of eye care continues to evolve, guided by research, technology, and an unwavering commitment to improving patient outcomes. Let’s look at some of the most impactful refractive articles in Optometry Times this year. Read more: https://lnkd.in/dvjy3Ms6

We gathered a few of our favorite articles on the condition you're likely seeing most in your chair: Dry eye disease. Review what we've learned this year, and maybe take a few tips and tricks into 2025. #optometry #dryeye

Free 1 hour CE! Register at https://ow.ly/vzJ750UtsQl

A new study’s research team, co-led by the University of California Irvine, has discovered that accumulated DNA damage in the retina is a key contributor to age-related macular degeneration (AMD). In their study, which was recently published in Aging Cell, authors also found that targeting specific retinal cell types may lead to treatments that can slow or stop progression, according to a news release. Read more: https://lnkd.in/gjAQDDeH

The number of daily patient visits at the Sue Anschutz-Rodgers Eye Center significantly rise when ambient particulate matter (PM) levels in the Denver metro region increase, according to a study conducted by ophthalmology researchers at the University of Colorado School of Medicine. The research team noted the World Health Organization has declared climate change to be “the single biggest health threat facing humanity,” yet there are limited studies on the impact of climate change-related air pollution on ocular health. Analyzing more than 144,000 visits for ocular surface irritation and allergy at the center between October 2015 and January 2023, a team of researchers found that patient visits more than doubled during periods of elevated particulate matter from air pollution. Read more: https://lnkd.in/eTnF6tuT

The EnVision Summit is nearly upon us, and Bonnie An Henderson, MD, the cofounder and program director, sat down with Sheryl Stevenson of the Eye Care Network to chat about the meeting. Henderson shares the historical values of the meeting and what attendees can expect this year. This year's Summit will take place in Puerto Rico, February 14-17, 2025. Watch the interview: https://lnkd.in/eMWy5snc